Article

Naringin, an agent for statin-associated diabetes: A preliminary study

2022-05-05

Abstract excerpt

Statins have long been used to treat hypercholesterolemia and are the highest prescribed class of drugs for this condition. Though generally considered safe, new pieces of evidence has increasingly linked them with the development of diabetes amongst users. The risk of development of diabetes is both drug and patient dependent. Amongst the numerous hypotheses proposed to explain this, one suggests that the develop...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1ee10199-9658-5a34-bf67-c47fe5bb439d
DOI: 10.21203/rs.3.rs-1600023/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 9 closest

Naringin, an agent for statin-associated diabetes: A preliminary studyDOI 10.21203/rs.3.rs-1600023/v1Read

Aaptamine Counteracts Statin-Induced PCSK9 Elevation to Improve LDL Receptor Expression and Cholesterol UptakeSemantic proximity Read

Do statins increase the risk of diabetes or is it guilt by association?Semantic proximity Read

Non-cardiovascular effects associated with statins.Semantic proximity Read

Naringin Inhibits Macrophage Foam Cell Formation by Regulating Lipid Homeostasis and Metabolic Phenotype.Semantic proximity Read

Restoration of the adipogenic gene expression by naringenin and naringin in 3T3-L1 adipocytesSemantic proximity Read

Naringin, the major grapefruit flavonoid, specifically affects atherosclerosis development in diet-induced hypercholesterolemia in miceSemantic proximity Read

Bradykinin Potentiating Factor from Egyptian Honey Bee Venom Fraction: A Potential Therapeutic Agent for Type 1 DiabetesSemantic proximity Read

A food supplement having Adiponectin Agonist propertiesSemantic proximity Read

Antihypertensive Drug Guanabenz Is Active In Vivo against both Yeast and Mammalian PrionsSemantic proximity Read